Estimates of effectiveness of SARS-CoV-2 vaccines against symptomatic infection from observational studies may be biased if testing rates differ according to vaccination status. Here, the authors use simulations to quantify the impact of this testing bias in retrospective cohort and test-negative study designs.
- Korryn Bodner
- Linwei Wang
- Sharmistha Mishra
